Evidence map›Paper›PMID 31470665›Full record

ArticleMolecules (Basel, Switzerland)2019

Identification of New Antifungal Agents Targeting Chitin Synthesis by a Chemical-Genetic Method.

Yan Li, Hongmin Sun, Xiaohong Zhu, Cong Bian, Yanchang Wang, Shuyi Si

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Clinical Isolate ofOpen journal of medical microbiology · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Solid-state NMR analysis of unlabeled fungal cell walls fromJournal of structural biology: X · 2022
    Article
  8. Prospects for anti-Cell surface (Amsterdam, Netherlands) · 2021
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Yan LiBeijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100050, China.
Hongmin SunBeijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100050, China.
Xiaohong ZhuBeijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100050, China.
Cong BianBeijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100050, China.
Yanchang WangDepartment of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee, FL 32306, USA. sisyimb@hotmail.com.
Shuyi SiBeijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100050, China. yanchang.wang@med.fsu.edu.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNFlorida State University · US

Funding

National Natural Science Foundation of China 81529003
6 · The paper itself

Abstract

Fungal infection is a leading cause of mortality in immunocompromised population; thus, it is urgent to develop new and safe antifungal agents. Different from human cells, fungi have a cell wall, which is composed mainly of polysaccharide glucan and chitin. The unique cell wall structure is an ideal target for antifungal drugs. In this research, a chemical-genetic method was used to isolate antifungal agents that target chitin synthesis in yeast cells. From a compound library, we isolated two benzothiazole compounds that showed greater toxicity to yeast mutants lacking glucan synthase Fks1 compared to wild-type yeast cells and mutants lacking chitin synthase Chs3. Both of them inhibited the activity of chitin synthase in vitro and reduced chitin level in yeast cells. Besides, these compounds showed clear synergistic antifungal effect with a glucan synthase inhibitors caspofungin. Furthermore, these compounds inhibited the growth of

Indexed as

Gene Expression Regulation, FungalAntifungal AgentsBenzothiazolesCandida albicansCaspofunginCell WallChitinChitin SynthaseDrug CombinationsDrug DiscoveryDrug SynergismEchinocandinsGene Expression ProfilingGlucosyltransferasesHigh-Throughput Screening AssaysMembrane ProteinsAntifungal AgentsBenzothiazolesCaspofunginChitinChitin SynthaseCHS3 protein, S cerevisiaeDrug CombinationsEchinocandinsFKS1 protein, S cerevisiaeGlucosyltransferasesMembrane ProteinsSaccharomyces cerevisiae ProteinsSmall Molecule Librariesantifungal agentsCandida albicanschitinglucanSaccharomyces cerevisiae

Identifiers

PMID31470665
PMCPMC6749524
OpenAlexW2970104886

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.